论文部分内容阅读
目的分析莫西沙星治疗成人支原体肺炎的临床疗效。方法 86例成人支原体肺炎患者,按照入院时间分为对照组和实验组,各43例。对照组患者给予阿奇霉素治疗,实验组患者给予莫西沙星治疗。比较两组患者的临床治疗效果和不良反应。结果实验组患者的临床治疗总有效率高于对照组,不良反应发生率低于对照组,差异均具有统计学意义(P<0.05)。结论在成人支原体肺炎治疗中,采用莫西沙星治疗,其治疗效果显著,同时可降低不良反应,具有临床应用价值。
Objective To analyze the clinical efficacy of moxifloxacin in the treatment of mycoplasma pneumonia in adults. Methods 86 cases of adult mycoplasma pneumonia patients were divided into control group and experimental group according to the admission time, 43 cases in each group. Patients in the control group were treated with azithromycin, and patients in the experimental group were treated with moxifloxacin. The clinical effects and adverse reactions of the two groups were compared. Results The total effective rate of clinical treatment in experimental group was higher than that of control group, and the incidence of adverse reactions was lower than that of control group. The difference was statistically significant (P <0.05). Conclusion In the treatment of adult mycoplasma pneumonia, the use of moxifloxacin treatment, the treatment of significant effect, while reducing adverse reactions, with clinical value.